CIT and systemic lupus erythematosus: Most importantly, antibody responses to control reverse LL37 (REV) and cit-REV peptide were negative in SLE, which suggests that circulating SLE antibodies truly recognized cit-LL37 and not merely citrulline (Fig. 2B).